Agomab (@agomab_) 's Twitter Profile
Agomab

@agomab_

Agomab translates its deep expertise in growth factor biology to pioneer novel treatments that aim to resolve fibrotic-related processes.

ID: 1491758772192223234

calendar_today10-02-2022 13:00:46

33 Tweet

103 Followers

83 Following

Agomab (@agomab_) 's Twitter Profile Photo

Today we announced that AGMB-129 received FDA Fast Track Designation for fibrostenosing Crohn’s Disease and that our Phase 2a STENOVA trial is underway. Two crucial steps in addressing this unmet medical need: agomab.com/news-events/#n… #FDAFastTrack #CrohnsDisease #Biotech

Today we announced that AGMB-129 received FDA Fast Track Designation for fibrostenosing Crohn’s Disease and that our Phase 2a STENOVA trial is underway. Two crucial steps in addressing this unmet medical need: agomab.com/news-events/#n…
#FDAFastTrack #CrohnsDisease #Biotech